TY - JOUR
T1 - A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries
T2 - a narrative review
AU - Sawan, Mouna
AU - Reeve, Emily
AU - Turner, Justin
AU - Todd, Adam
AU - Steinman, Michael A.
AU - Petrovic, Mirko
AU - Gnjidic, Danijela
N1 - Funding Information:
This manuscript was not funded. Dr Gnjidic is funded by the Australian National Health and Medical Research Council (NHMRC) Dementia Leadership Fellow. Dr. Steinman?s participation was funded by the U.S. National Institute on Aging [grants K24AG049057 and R24AG064025]. Dr Reeve is supported by a National Health and Medical Research Council (NHMRC) Dementia Research Development Fellowship. Dr Turner is supported by a MITACS Elevate Fellowship.
Publisher Copyright:
© 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2020/3/3
Y1 - 2020/3/3
N2 - Introduction: There is increasing recognition of the need for deprescribing of inappropriate medications in older adults. However, efforts to encourage implementation of deprescribing in clinical practice have resulted in mixed results across settings and countries. Area covered: Searches were conducted in PubMed, Embase, and Google Scholar in June 2019. Reference lists, citation checking, and personal reference libraries were also utilized. Studies capturing the main challenges of, and opportunities for, implementing deprescribing into clinical practice across selected health-care settings internationally, and international deprescribing-orientated policies were included and summarized in this narrative review. Expert opinion: Deprescribing intervention studies are inherently heterogeneous because of the complexity of interventions employed and often do not reflect the real-world. Further research investigating enhanced implementation of deprescribing into clinical practice and across health-care settings is required. Process evaluations in deprescribing intervention studies are needed to determine the contextual factors that are important to the translation of the interventions in the real-world. Deprescribing interventions may need to be individually tailored to target the unique barriers and opportunities to deprescribing in different clinical settings. Introduction of national policies to encourage deprescribing may be beneficial, but need to be evaluated to determine if there are any unintended consequences.
AB - Introduction: There is increasing recognition of the need for deprescribing of inappropriate medications in older adults. However, efforts to encourage implementation of deprescribing in clinical practice have resulted in mixed results across settings and countries. Area covered: Searches were conducted in PubMed, Embase, and Google Scholar in June 2019. Reference lists, citation checking, and personal reference libraries were also utilized. Studies capturing the main challenges of, and opportunities for, implementing deprescribing into clinical practice across selected health-care settings internationally, and international deprescribing-orientated policies were included and summarized in this narrative review. Expert opinion: Deprescribing intervention studies are inherently heterogeneous because of the complexity of interventions employed and often do not reflect the real-world. Further research investigating enhanced implementation of deprescribing into clinical practice and across health-care settings is required. Process evaluations in deprescribing intervention studies are needed to determine the contextual factors that are important to the translation of the interventions in the real-world. Deprescribing interventions may need to be individually tailored to target the unique barriers and opportunities to deprescribing in different clinical settings. Introduction of national policies to encourage deprescribing may be beneficial, but need to be evaluated to determine if there are any unintended consequences.
KW - Deprescribing
KW - deprescribing in practice
KW - medication withdrawal
KW - older adults
KW - policies
KW - polypharmacy
UR - http://www.scopus.com/inward/record.url?scp=85080118768&partnerID=8YFLogxK
U2 - 10.1080/17512433.2020.1730812
DO - 10.1080/17512433.2020.1730812
M3 - Review Article
C2 - 32056451
AN - SCOPUS:85080118768
SN - 1751-2433
VL - 13
SP - 233
EP - 245
JO - Expert Review of Clinical Pharmacology
JF - Expert Review of Clinical Pharmacology
IS - 3
ER -